Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $52.3B |
| FY2017, ended Dec 31, 2017 | $60.4B |
| FY2018, ended Dec 31, 2018 | $45.3B |
| FY2019, ended Dec 31, 2019 | $51.1B |
| FY2020, ended Dec 31, 2020 | $42.6B |
| FY2021, ended Dec 31, 2021 | $57.9B |
| FY2022, ended Dec 31, 2022 | $68.1B |
| FY2023, ended Dec 31, 2023 | $71.1B |
| FY2024, ended Dec 31, 2024 | $71.2B |
| FY2025, ended Dec 31, 2025 | $91.0B |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | $94.4B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.6B |
| FY2017, ended Dec 31, 2017 | $31.0B |
| FY2018, ended Dec 31, 2018 | $36.2B |
| FY2019, ended Dec 31, 2019 | $39.4B |
| FY2020, ended Dec 31, 2020 | $37.9B |
| FY2021, ended Dec 31, 2021 | $38.5B |
| FY2022, ended Dec 31, 2022 | $39.4B |
| FY2023, ended Dec 31, 2023 | $42.3B |
| FY2024, ended Dec 31, 2024 | $47.7B |
| FY2025, ended Dec 31, 2025 | $52.5B |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | $53.8B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.57B | $1.77B |
| FY2017, ended Dec 31, 2017 | $2.91B | $3.45B |
| FY2018, ended Dec 31, 2018 | $3.35B | $2.46B |
| FY2019, ended Dec 31, 2019 | $3.48B | $1.99B |
| FY2020, ended Dec 31, 2020 | $3.17B | $2.89B |
| FY2021, ended Dec 31, 2021 | $3.26B | $3.38B |
| FY2022, ended Dec 31, 2022 | $3.39B | $3.46B |
| FY2023, ended Dec 31, 2023 | $3.31B | $3.81B |
| FY2024, ended Dec 31, 2024 | $3.78B | $3.20B |
| FY2025, ended Dec 31, 2025 | $4.21B | $3.96B |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | $4.34B | $6.20B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.33B |
| FY2017, ended Dec 31, 2017 | $2.98B |
| FY2018, ended Dec 31, 2018 | $963M |
| FY2019, ended Dec 31, 2019 | $902M |
| FY2020, ended Dec 31, 2020 | $2.82B |
| FY2021, ended Dec 31, 2021 | $1.60B |
| FY2022, ended Dec 31, 2022 | $1.24B |
| FY2023, ended Dec 31, 2023 | $1.91B |
| FY2024, ended Dec 31, 2024 | $1.70B |
| FY2025, ended Dec 31, 2025 | $2.33B |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | $3.65B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.89B |
| FY2017, ended Dec 31, 2017 | $4.03B |
| FY2018, ended Dec 31, 2018 | $12.5B |
| FY2019, ended Dec 31, 2019 | $12.0B |
| FY2020, ended Dec 31, 2020 | $13.1B |
| FY2021, ended Dec 31, 2021 | $11.6B |
| FY2022, ended Dec 31, 2022 | $10.6B |
| FY2023, ended Dec 31, 2023 | $9.34B |
| FY2024, ended Dec 31, 2024 | $8.83B |
| FY2025, ended Dec 31, 2025 | $8.07B |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | $8.01B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 10.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 303M |
| FY2017, ended Dec 31, 2017 | 297M |
| FY2018, ended Dec 31, 2018 | 288M |
| FY2019, ended Dec 31, 2019 | 290M |
| FY2020, ended Dec 31, 2020 | 286M |
| FY2021, ended Dec 31, 2021 | 278M |
| FY2022, ended Dec 31, 2022 | 274M |
| FY2023, ended Dec 31, 2023 | 274M |
| FY2024, ended Dec 31, 2024 | 270M |
| FY2025, ended Dec 31, 2025 | 270M |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | 270M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.00B | $95.0M |
| FY2017, ended Dec 31, 2017 | $1.56B | $123M |
| FY2018, ended Dec 31, 2018 | $1.77B | $140M |
| FY2019, ended Dec 31, 2019 | $231M | $133M |
| FY2020, ended Dec 31, 2020 | $587M | $128M |
| FY2021, ended Dec 31, 2021 | $1.83B | $126M |
| FY2022, ended Dec 31, 2022 | $1.23B | $165M |
| FY2023, ended Dec 31, 2023 | $434M | $181M |
| FY2024, ended Dec 31, 2024 | $1.50B | $183M |
| FY2025, ended Dec 31, 2025 | $637M | $196M |
| Trailing 12 months to Apr 5, 2026 (through Q1 FY2026) | $254M | $202M |
Valuation
At current price- Market Cap
- $96.0B
- P/E
- 22.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.8×
- Price / Book
- 3.7×
- EV / EBITDA
- 15.6×
Growth
Trailing 12 months- Revenue (TTM)
- $53.8B
- Revenue Growth YoY
- 9.3%
- Revenue CAGR 3Y
- 10.1%
- Revenue CAGR 5Y
- 6.7%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 9.2%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 10.2%
- Net Margin
- 8.1%
- FCF Margin
- 11.5%
- Return on Equity
- 18.0%
Earnings
Trailing 12 months- Net Income
- $4.34B
- EPS (diluted)
- —
- EBITDA
- $6.44B
- Operating Income
- $5.51B
Balance Sheet
As of Apr 5, 2026- Cash and cash equivalents
- $3.65B
- Total Debt
- $8.01B
- Net Debt
- $4.36B
- Total Assets
- $59.0B
- Total Liabilities
- $33.0B
- Shareholders' Equity
- $26.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.42B
- Capital Expenditure
- $1.22B
- Free Cash Flow
- $6.20B
Dividends and risk
Last 12 months- Dividend Yield
- 1.8%
- Dividend / Share
- $6.27
- Beta (5Y)
- 0.33
Every ratio is calculated from the company’s reported figures.